An induced pluripotent stem cell line (SDQLCHi006-A) derived from a patient with maple syrup urine disease type Ib carrying compound heterozygous mutations of p.R168C and p.T322I in BCKDHB gene

An induced pluripotent stem cell line (SDQLCHi006-A) derived from a patient with maple syrup urine disease type Ib carrying compound heterozygous mutations of p.R168C and p.T322I in BCKDHB gene

Maple syrup urine disease type Ib (MSUD Ib) is an autosomal recessive genetic metabolic disease caused by homozygous or compound heterozygous mutation in BCKDHB on chromosome 6q14. We generated an induced pluripotent stem cell (iPSC) line from peripheral blood mononuclear cells (PBMCs) of a 5-day-ol...

Full description

Bibliographic Details
Main Authors:	Yue Li, Haiyan Zhang, Beibei Yan, Yanyan Ma, Xiaomeng Yang, Jingyun Guan, Yuqiang Lv, Min Gao, Jian Ma, Zhongtao Gai, Yi Liu
Format:	Article
Language:	English
Published:	Elsevier 2019-10-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506119302090

Similar Items

An induced pluripotent stem cell line (SDQLCHi033-A) derived from a patient with maple syrup urine disease type Ib carrying a homozygous mutation in BCKDHB gene
by: Bin Wang, et al.
Published: (2021-01-01)

Two novel mutations in the BCKDHB gene that cause maple syrup urine disease
by: Bingjuan Han, et al.
Published: (2018-10-01)

An integration-free iPSC line (SDQLCHi013-A) derived from a patient with maple syrup urine disease carrying compound heterozygote mutations in BCKDHA gene
by: Haiyan Zhang, et al.
Published: (2019-12-01)

Fourteen new mutations of BCKDHA, BCKDHB and DBT genes associated with maple syrup urine disease (MSUD) in Malaysian population
by: Ernie Zuraida Ali, et al.
Published: (2018-12-01)

A Novel Whole Gene Deletion of BCKDHB by Alu-Mediated Non-allelic Recombination in a Chinese Patient With Maple Syrup Urine Disease
by: Gang Liu, et al.
Published: (2018-04-01)

Twenty novel mutations in BCKDHA, BCKDHB and DBT genes in a cohort of 52 Saudi Arabian patients with maple syrup urine disease
by: Faiqa Imtiaz, et al.
Published: (2017-06-01)

Establishment of a human induced pluripotent stem cell line (SDQLCHi005-A) from a patient with mastocytosis carrying heterozygous mutation in KIT gene
by: Haiyan Zhang, et al.
Published: (2019-10-01)

Establishment of a human induced pluripotent stem cell line (SDQLCHi004-A) from a patient with nemaline myopathy-4 disease carrying heterozygous mutation in TPM2 gene
by: Yanyan Ma, et al.
Published: (2019-10-01)

Generation of an induced pluripotent stem cell line (SDQLCHi003-a) from a patient with short rib-thoracic dysplasia syndrome type III carrying compound heterozygous mutations in DYNC2H1
by: Haiyan Zhang, et al.
Published: (2019-08-01)

Establishment of a human iPSC line (SDQLCHi010-A) from a patient with optic nerve malformation carrying a heterozygous mutation in PAX6 gene
by: Haiyan Zhang, et al.
Published: (2019-12-01)

Identification of novel mutations in BCKDHB and DBT genes in Vietnamese patients with maple sirup urine disease
by: Thi T. N. Nguyen, et al.
Published: (2020-08-01)

Generation of a Human iPSC line (SDQLCHi021-A) from a patient with methylmalonic acidemia cblC type carrying compound heterozygous mutations in MMAHC gene
by: Jingyun Guan, et al.
Published: (2020-03-01)

Reprogramming of human peripheral blood mononuclear cell (PBMC) from a patient suffering from hearing loss into iPSC line (SDQLCHi035-A) maintaining compound heterozygous variations in GJB2 gene
by: Xiaomeng Yang, et al.
Published: (2021-03-01)

Establishment of a human induced pluripotent stem cell line (SDQLCHi037-A) from a patient with Alagille syndrome carrying heterozygous mutation in JAG1 gene
by: Bin Wang, et al.
Published: (2021-03-01)

Maple Syrup Disease: Diagnosis and Therapy
by: J Gordon Millichap
Published: (2002-06-01)

An integration-free iPSC line (SDQLCHi017-A) derived from a patient with nemaline myopathy-2 disease carrying compound heterozygote mutations in NEB gene
by: Yanyan Ma, et al.
Published: (2020-03-01)

The Drosophila model of Maple Syrup Urine Disease
by: Yu-Min Chen, et al.
Published: (2017)

Maple Syrup Urine Disease and Cerebral Edema
by: J Gordon Millichap
Published: (1991-09-01)

Menkes Maple Syrup Urine Disease: Treatment
by: J Gordon Millichap
Published: (1991-02-01)

Maple syrup urine disease: mechanisms and management
by: Blackburn PR, et al.
Published: (2017-09-01)

Intramyelinic edema in maple syrup urine disease
by: Leema Pauline Cornelius, et al.
Published: (2014-01-01)

The Role of Apoptosis in Maple Syrup Urine Disease
by: Lesay, Adeline
Published: (2010)

Induced pluripotent stem cell line (SDQLCHi041-A) from a male patient with mucopolysaccharidosis type IIIB
by: Jingyun Guan, et al.
Published: (2021-04-01)

Generation of an induced pluripotent stem cell line (SDQLCHi009-A) from a patient with 47,XXY and ornithine transcarbamylase deficiency carrying a hemizygote mutation in OTC
by: Xiaomeng Yang, et al.
Published: (2020-03-01)

A non-integrated iPSC line (SDQLCHi042-A) from a boy suffering from familial combined hyperlipidemia with compound heterozygous mutations of lipoprotein lipase gene
by: Zilong Li, et al.
Published: (2021-05-01)

Maple syrup urine disease: the first case in Bali
by: Putu Andina Pramitasari, et al.
Published: (2018-04-01)

Maple Syrup Urine Disease Complicated with Kyphoscoliosis and Myelopathy
by: Jia-Woei Hou
Published: (2016-10-01)

Relationship of the chemical constituents of maple sugar and sand to the amount formed during maple syrup processing /
by: Gallander, James Francis
Published: (1964)

Pregnancy in an adolescent with maple syrup urine disease: Case report
by: Michelle E. Abadingo, et al.
Published: (2021-06-01)

Establishment of a non-integrate iPS cell line (SDQLCHi023-A) from a patient with Xq25 microduplication syndrome carrying a 1.3 Mb hemizygote duplication at chrXq25
by: Xiaomeng Yang, et al.
Published: (2021-03-01)

Generation of a human induced pluripotent stem cell line (SDQLCHi036-A) from a patient with ornithine transcarbamylase deficiency carrying a deletion involving 3–9 exons of OTC gene
by: Jingyun Guan, et al.
Published: (2021-04-01)

Generation of an iPSC line (SDQLCHi015-A) from peripheral blood mononuclear cells of a patient with mental retardation type 15 carrying c.1007_1011del, p.(Ile336fs) in CUL4B gene
by: Jingyun Guan, et al.
Published: (2019-12-01)

An integration-free iPSC line (SDQLCHi012-A) derived from a patient with inflammatory bowel disease- 28 carrying compound heterozygote mutations in IL10RA gene
by: Yanyan Ma, et al.
Published: (2019-12-01)

Generation and characterization of an induced pluripotent stem cell line SDQLCHi018-A from a congenital myasthenic syndrome patient carrying compound heterozygote mutations in RAPSN gene
by: Haiyan Zhang, et al.
Published: (2021-03-01)

Leucinosis, or maple syrup urine disease (lecture and a clinical case)
by: Ju. A. Tsareva, et al.
Published: (2020-10-01)

Nutrient management in the intrapartum period in maternal maple syrup urine disease
by: Chika Takano, et al.
Published: (2021-03-01)

Assessing the Growth Potential and Economic Impact of the U.S. Maple Syrup Industry
by: Michael L. Farrell, et al.
Published: (2016-07-01)

Maple Syrup Urine Disease in a Central Indiana Hereford Herd
by: Mark E. Robarge, et al.
Published: (2015-01-01)

Skin Lesions Associated with Nutritional Management of Maple Syrup Urine Disease
by: Jaraspong Uaariyapanichkul, et al.
Published: (2017-01-01)

Interannual and spatial variability of maple syrup yield as related to climatic factors
by: Louis Duchesne, et al.
Published: (2014-06-01)